세계의 뉴클레오티드 보충제 시장 보고서(2025년)
Nucleotides Supplements Global Market Report 2025
상품코드 : 1889524
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,532,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,442,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,352,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

세계의 뉴클레오티드 보충제 시장 규모는 급속히 확대되고 있습니다. 2024년 24억 9,000만 달러에서 2025년에는 27억 8,000만 달러로, CAGR 11.6%로 성장이 전망되고 있습니다. 지난 몇 년간의 성장은 면역 및 세포 건강에 대한 소비자의 의식 향상, 기능성 식품 및 영양 보조 식품 수요 증가, 만성 질환의 유병률 상승, 유아 영양 및 소아 건강 제품의 확대, 개별화 영양 솔루션의 보급 확대 등이 요인으로 생각됩니다.

뉴클레오티드 보충제 시장 규모는 향후 수년간 급속한 성장이 예상됩니다. 2029년까지 42억 7,000만 달러에 달하고, CAGR은 11.3%가 될 전망입니다. 예측기간의 성장은 영양보조식품 및 의약품 분야에 대한 투자 증가, 뉴클레오티드 강화 기능성 식품 수요 증가, 스포츠 웰니스 분야에서 뉴클레오티드의 효능에 대한 인지도 향상, 온라인 플랫폼을 포함한 세계 유통 채널의 확대, 인간 및 동물 건강 분야에서 뉴클레오티드 용도 조사의 진전에 의해 견인될 것으로 전망됩니다. 예측기간의 주요 동향으로는 뉴클레오티드의 제제화 및 전달 기술의 진보, 생물활성 뉴클레오티드 보충제 혁신, 유아 및 소아용 조제 분유의 영양 강화 개발, 뉴클레오티드 베이스 치료제의 연구 개발, 고생물학적 이용능 및 안정화 뉴클레오티드 제품의 진전 등을 들 수 있습니다.

영양 보충제 수요 증가는 향후 몇 년 동안 뉴클레오티드 보충제 시장의 성장을 이끌 것으로 예측됩니다. 영양 보충제에는 식사를 보완하고 종합적인 건강을 지원하도록 설계된 비타민, 미네랄, 아미노산 및 기타 영양소와 같은 다양한 제품이 포함됩니다. 소비자의 건강 의식이 높아짐에 따라 예방 의료와 웰빙에 대한 중시가 증가하고 있으며, 이 수요는 증가하는 경향이 있습니다. 영양 보충제의 한 분야인 뉴클레오티드 보충제는 세포 복구, 면역 기능 및 대사 건강을 지원하는 데 사용됩니다. 예를 들어, 2025년 9월에 호주 통계국이 발표한 데이터에 의하면, 2023년에는 약 3명 중 1명(33.6%)이 영양 보조 식품을 이용하고 있어, 성인 여성(43.7%)의 이용률이 성인 남성(30.8%)에 비해 현저하게 높은 것이 밝혀졌습니다. 따라서 영양 보충제에 대한 관심 증가는 뉴클레오타이드 보충제 시장의 확대에 기여하고 있습니다.

뉴클레오티드 보충제 시장에서 사업을 전개하는 기업은 동물의 면역 기능, 성장 및 전반적인 건강을 증진하는 조사를 뒷받침하는 고급 처방으로 제품 포트폴리오를 확대하는 데 주력하고 있습니다. 예를 들어, 2025년 10월에는 스페인 제약 회사 Bioiberica가 Nucleoforce 제품 라인에 3개의 새로운 뉴클레오티드 원료를 추가했습니다. Nucleoforce Immunity, Nucleoforce Performance, Nucleoforce High Flowability(HF)입니다. 이 원료는 반려동물, 가축, 수산 양식 종에서 면역 건강, 성장 및 생산 효율을 지원하기 위해 설계되었습니다. 효모에서 천연 유래의 이러한 뉴클레오티드 농축 물은 스트레스 단계, 빠른 성장 단계, 영양 불량시 동물을 돕습니다. 초기 연구에 따르면, 특히 해초 가루 및 올리브 추출물과 같은 생물학적 활성 화합물과 결합함으로써 Nucleoforce는 성장 촉진 및 질병 저항성 향상에 기여할 수 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

JHS
영문 목차

영문목차

Nucleotide supplements are bioactive nutritional compounds that provide purified nucleotide molecules composed of a nitrogenous base, a sugar, and phosphate groups essential for DNA, RNA, and energy metabolism in cells. They are designed to support cellular repair, immune health, and metabolic efficiency by supplying exogenous nucleotides during conditions where internal synthesis is insufficient.

The key product types in nucleotide supplements are DNA nucleotides, RNA nucleotides, and others. DNA nucleotides are the molecular building blocks of deoxyribonucleic acid, carrying hereditary information and ensuring the accurate transfer of genetic material during cell division and reproduction. They consist of nitrogenous bases, including pyrimidines and purines. These supplements are distributed through channels such as online stores, supermarkets or hypermarkets, specialty stores, and others. Their applications span pharmaceuticals, food, animal feed additives, and drug discovery, serving end-users across the health and wellness sector, pharmaceutical industry, nutraceutical companies, and the food and beverage industry.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The nucleotides supplements market research report is one of a series of new reports from The Business Research Company that provides nucleotides supplements market statistics, including the nucleotides supplements industry global market size, regional shares, competitors with the nucleotides supplements market share, detailed nucleotides supplements market segments, market trends, and opportunities, and any further data you may need to thrive in the nucleotides supplements industry. This nucleotides supplements market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The nucleotide supplements market size has grown rapidly in recent years. It will grow from $2.49 billion in 2024 to $2.78 billion in 2025 at a compound annual growth rate (CAGR) of 11.6%. The growth in the historic period can be linked to growing consumer awareness about immune and cellular health, increasing demand for functional foods and dietary supplements, rising prevalence of chronic diseases, expansion of infant nutrition and pediatric health products, and increasing adoption of personalized nutrition solutions.

The nucleotide supplements market size is expected to see rapid growth in the next few years. It will grow to $4.27 billion in 2029 at a compound annual growth rate (CAGR) of 11.3%. The growth in the forecast period can be driven by increasing investment in the nutraceutical and pharmaceutical sectors, growing demand for nucleotide-enriched functional foods, rising awareness about nucleotide benefits in sports and wellness, expansion of global distribution channels including online platforms, and increasing research on nucleotide applications in human and animal health. Major trends in the forecast period include advancements in nucleotide formulation and delivery, innovations in bioactive nucleotide supplements, developments in infant and pediatric formula enrichment, research and developments in nucleotide-based therapeutics, and advancements in high-bioavailability and stabilized nucleotide products.

The rising demand for dietary supplements is expected to drive the growth of the nucleotide supplements market in the coming years. Dietary supplements include a wide variety of products such as vitamins, minerals, amino acids, and other nutrients designed to complement the diet and support overall health. This demand is increasing as health awareness among consumers grows, leading to a greater emphasis on preventive healthcare and wellness. Nucleotide supplements, a specific category of dietary supplement, are used to support cellular repair, immune function, and metabolic health. For example, in September 2025, the Australian Bureau of Statistics reported that in 2023, approximately one in three individuals (33.6%) used dietary supplements, with a notably higher usage rate among adult females (43.7%) compared to adult males (30.8%). Therefore, the growing interest in dietary supplements is contributing to the expansion of the nucleotide supplements market.

Companies operating in the nucleotide supplements market are focusing on expanding their product portfolios with advanced, research-backed formulations that enhance immune function, growth, and overall health in animals. For example, in October 2025, Bioiberica, a Spain-based pharmaceutical company, expanded its Nucleoforce line with three new nucleotide-based ingredients: Nucleoforce Immunity, Nucleoforce Performance, and Nucleoforce High Flowability (HF). These ingredients are designed to support immune health, growth, and production efficiency in pets, livestock, and aquaculture species. Derived naturally from yeast, these nucleotide concentrates help animals during periods of stress, rapid development, or poor nutrition. Early research suggests that Nucleoforce can improve growth and disease resistance, especially when combined with bioactive compounds such as seaweed meal and olive extract.

In July 2025, Sudeep Pharma Limited, an India-based manufacturer of pharmaceutical and food-grade mineral ingredients, acquired Nutrition Supplies Services (NSS) for an undisclosed amount. Through this acquisition, Sudeep Pharma aims to expand its global presence in the infant formula and clinical nutrition sectors by integrating advanced micronutrient and nucleotide premix capabilities into its specialty ingredient portfolio. NSS, an Ireland-based company, specializes in advanced micronutrient premixes, including blends of amino acids and nucleotides, primarily for infant and clinical nutrition.

Major companies operating in the nucleotides supplements market are Cargill Incorporated, BASF SE, Merck KGaA, Thermo Fisher Scientific Inc., Evonik Industries AG, Lallemand Inc., Integrated DNA Technologies Inc., Promega Corporation, Takara Bio Inc., GenScript Biotech Corporation, Bioiberica S.A.U., Bluebonnet Nutrition Corporation, Elysium Health Inc., Ajinomoto Health & Nutrition North America Inc., InVite Health Inc., Leiber GmbH, TriLink BioTechnologies LLC, Bio Basic Inc., Creative Biogene Inc., Jena Bioscience GmbH, GeneCopoeia Inc., Quantum Nutrition Labs LLC, GMPriority Pharma Inc.

North America was the largest region in the nucleotide supplements market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in nucleotide supplements report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the nucleotide supplements market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The nucleotide supplements market consists of sales of purified nucleotide ingredients and formulated nucleotide supplement products such as powders, capsules, premixes, DNA nucleotides, and RNA nucleotides. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Nucleotides Supplements Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on nucleotides supplements market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for nucleotides supplements ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The nucleotides supplements market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Nucleotides Supplements Market Characteristics

3. Nucleotides Supplements Market Trends And Strategies

4. Nucleotides Supplements Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Nucleotides Supplements Growth Analysis And Strategic Analysis Framework

6. Nucleotides Supplements Market Segmentation

7. Nucleotides Supplements Market Regional And Country Analysis

8. Asia-Pacific Nucleotides Supplements Market

9. China Nucleotides Supplements Market

10. India Nucleotides Supplements Market

11. Japan Nucleotides Supplements Market

12. Australia Nucleotides Supplements Market

13. Indonesia Nucleotides Supplements Market

14. South Korea Nucleotides Supplements Market

15. Western Europe Nucleotides Supplements Market

16. UK Nucleotides Supplements Market

17. Germany Nucleotides Supplements Market

18. France Nucleotides Supplements Market

19. Italy Nucleotides Supplements Market

20. Spain Nucleotides Supplements Market

21. Eastern Europe Nucleotides Supplements Market

22. Russia Nucleotides Supplements Market

23. North America Nucleotides Supplements Market

24. USA Nucleotides Supplements Market

25. Canada Nucleotides Supplements Market

26. South America Nucleotides Supplements Market

27. Brazil Nucleotides Supplements Market

28. Middle East Nucleotides Supplements Market

29. Africa Nucleotides Supplements Market

30. Nucleotides Supplements Market Competitive Landscape And Company Profiles

31. Nucleotides Supplements Market Other Major And Innovative Companies

32. Global Nucleotides Supplements Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Nucleotides Supplements Market

34. Recent Developments In The Nucleotides Supplements Market

35. Nucleotides Supplements Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기